Clinical Trial Update: A Placebo-controlled Trial to Evaluate the Safety and Efficacy of Galantamine in the Treatment of Vascular Dementia [Phase 3]

View source ↗

Summary

This update reports the completion of a Phase 3 placebo-controlled trial evaluating galantamine for vascular dementia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vascular Dementia

Drugs mentioned

• Galantamine (galantamine)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Dementia, Vascular | Phase 3 | Status: COMPLETED